Ocular Manifestations Prevalent in LCHAD Deficiency
Current estimates suggest that about half of patients with long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency may suffer from retinopathy.
LCFAOD Insights
New Insights Into the Management of Carnitine-Acylcarnitine Translocase Deficiency
Until recently, only 68 cases of CACTD had been reported in the literature. This number increased to 87 with a recent publication by Ryder et al.
How Knowledge of Fatty Acid Oxidation Guides Treatment of LCFAOD
How does our comprehension of fatty acid oxidation impact the management of long chain fatty acid oxidation disorder?
Reviewing the Benefits of Triheptanoin in Long Chain Fatty Acid Oxidation Disorder
Triheptanoin is clinically promising for LCFAOD, although challenges remain in quantifying its effects as a reliable biochemical marker.
Current Approaches to Treating Long Chain Fatty Acid Oxidation Disorder
Long chain fatty acid oxidation disorder (LCFAOD) is a rare and life-threatening disease that is inherited in an autosomal recessive manner. It impairs the body’s production of energy, which leads to chronic energy insufficiency and injury to the organs that depend on it. Although LCFAOD is screened for in newborns, current management strategies still too…
Carrier Screening for Autosomal Recessive and X-Linked Conditions
A study published in Genetics In Medicine sought to develop and answer a series of questions regarding the process of screening for carriers of a disease.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Insights
Loading... 
Loading...